Latest Asx News

MyEco Group launches a $2 million Series 2 convertible note offer targeting sophisticated investors, featuring a 10.5% annual interest and a 15% discount on share conversion prices.

InFocus Group Holdings has completed Codexa, a proprietary sweepstakes casino platform targeting the booming US market, with plans for licensing and potential sale.

Titomic Limited has secured a significant $1.7 million purchase order from the Netherlands’ Royal NLR, reinforcing its foothold in European aerospace and defense additive manufacturing.

Radiopharm Theranostics has initiated dosing in its Phase 1 clinical trial of RAD 402, a novel radiolabelled antibody targeting KLK3 in advanced prostate cancer. Early data from the trial’s initial dose levels are expected in the second half of 2026.

Latitude Group Holdings has finalised the margin and size for its Capital Notes 2 offer, setting a 4.15% annual margin and allocating $130 million following a successful bookbuild.

Finder Energy has achieved a pivotal regulatory milestone with approval of the Development Area for its Kuda Tasi and Jahal oil fields, setting the stage for project sanction and a scalable production hub in Timor-Leste.

Lodestar Minerals has appointed Executive Director Coraline Blaud as CEO, positioning the company to capitalise on its expanding exploration projects across multiple continents.

Winsome Resources Limited is set to be acquired by Li-FT Power Ltd through a scheme of arrangement, consolidating key lithium assets and creating a dual-listed entity on ASX and TSXV.

Eminence Minerals has completed the divestment of its Alturas Antimony Project to Maxus Mining, receiving cash and shares that bolster its balance sheet while maintaining exposure to antimony.

Forrestania Resources has agreed to acquire a substantial gold tenement package in Western Australia’s Eastern Goldfields, including the Karonie Gold Project with an inferred resource of 111,100 ounces. The $5 million deal combines cash and shares, reinforcing Forrestania’s regional growth strategy.

Redivium Limited advances its recapitalisation efforts and project development despite ASX suspension, withdrawing its European Green Bond and exploring new UK site options.

Osteopore Limited has drawn down an additional $250,000 on the second tranche of its redeemable convertible notes, continuing its strategic funding partnership with Advance Opportunities Fund. This incremental funding supports the company’s ongoing business and future growth initiatives.